CRISPR Therapeutics (CRSP) executive compensation, 2026 proxy

Samarth Kulkarni, Ph.D., Chief Executive Officer, was paid $7.7M in 2025, flat from $7.7M the year before. The CEO-to-median-employee pay ratio was 26:1, on median employee pay of $295,181.

Filed
April 21, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
1
CEO total pay
$7.7Mflat vs prior year
CEO to median employee
26:1median $295,181
Prior say-on-pay support
71%of votes cast
CEO Pay Ratio
26:1Compared to median employee
Median Employee Pay
$295,181Determined under SEC rules
CEO Total Compensation
$7,678,477For fiscal year 2025
Say on Pay Support
71%At the 2025 annual meeting

How Ph.D. was paid

$7.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Samarth Kulkarni, Ph.D.Chief Executive Officer$7,678,477

What changed and why

  • 71%71% of votes supported the say-on-pay proposal at the previous annual meeting.
  • $7.7MTotal compensation for the chief executive officer was $7,678,477 in 2025.
  • The ratio of chief executive officer pay to median employee pay was 26 to 1.
  • $295KThe median employee total annual compensation was $295,181 in 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.